1 – 10 of 190
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2025
- Thioamides adjacent to the ionizable amine headgroup in ionizable lipids reduce the pKa of lipid nanoparticles and enhance mRNA transfection efficiency in vitro and in vivo (2025) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION.
- Transcriptomic heterogeneity of nine complementary mouse TNBC models based on their comparative in vitro and in vivo characterization (2025) OncoPoint Symposium, 11th, Abstracts.
- A f entanyl hapten-displaying lipid nanoparticle vaccine that non-covalently encapsulates a TLR7/8 agonist and T-helper epitope induces protective anti-fentanyl immunity (2025) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 64(7).
- 2024
- CO-DELIVERY of glutamic acid-extended peptide antigen and imidazoquinoline TLR7/8 agonist via ionizable lipid nanoparticles induces protective anti-tumor immunity (2024) BIOMATERIALS. 311.
- Amplification of protein expression by self-amplifying mRNA delivered in lipid nanoparticles containing a β-aminoester ionizable lipid correlates with reduced innate immune activation (2024) ACS NANO. 18(41). p.28311-28324
- Less is more : self-amplifying mRNA becomes self-killing upon dose escalation in immune-competent retinal cells (2024) EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 196.
- PH-triggered, lymph node focused immunodrug release by polymeric 2-propionic-3-methyl-maleic anhydrides with cholesteryl end groups (2024) ADVANCED HEALTHCARE MATERIALS. 13(32).
- Immunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza (2024) NPJ VACCINES. 9(1).
- Combinatorial screening of biscarbamate ionizable lipids identifies a low reactogenicity lipid for lipid nanoparticle mRNA delivery (2024) ADVANCED FUNCTIONAL MATERIALS. 34(21). p.1-16
- Chitin-mediated blockade of chitinase-like proteins reduces tumor growth and immunosuppression in a mouse model for TNBC (2024) OncoPoint Symposium, 10th, Abstracts.